Article
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics.
Neuropathology and applied neurobiology - 1 Oct 2021
Crosier Stephen, Hicks Debbie, Schwalbe Edward C, Williamson Daniel, Leigh Nicholson Sarah, Smith Amanda, Lindsey Janet C, Michalski Antony, Pizer Barry, Bailey Simon, Bown Nick, Cuthbert Gavin, Wharton Stephen B, Jacques Thomas S, Joshi Abhijit, Clifford Steven C
Abstract excerpt
AIMS: Application of advanced molecular pathology in rare tumours is hindered by low sample numbers, access to specialised expertise/technologies and tissue/assay QC and rapid reporting requirements. We assessed the feasibility of co-ordinated real-time centralised pathology review (CPR), encompassing molecular diagnostics and contemporary genomics (RNA-seq/DNA methylation-array). METHODS: This nationwide trial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.